Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-055263

Director bought 1,500,000 shares at $2.00 ($3,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2022-10-31 Purchase +1,500,000 $2.00 $3,000,000 1,642,202 D
Open-market purchases · 1,500,000 sh · avg $2.00 · $3,000,000
Loading xslF345X03/doc4.xml…